MetaCap

Dr. Reddy's Laboratories Statistics

NYSE: RDYHealth CareBiotechnology: Pharmaceutical PreparationsUSD

14.89+0.06 (+0.40%)

At close: Nov 20, 4:00 PM ET · Delayed 15 min

Dr. Reddy's Laboratories by the numbers

Dr. Reddy's Laboratories has a market capitalization of $12.41 billion based on 833.66M shares outstanding. Its trailing P/E ratio is 41.4, and its forward P/E is 22.5. The stock trades 11.6% above its 50-day average and 11.9% above its 200-day average.

Average daily trading volume is 2.85M shares, or about $42.4 million in dollar volume.

Summary generated from market data by MetaCap's automated system. Methodology

RDY valuation vs. peer median

RDY compared with the median of 8 peer companies
MetricRDYPeer medianDifference
Market cap$12.41B$10.64B+17%
Forward P/E22.519.9+13%
Avg. volume2.85M1.56M+83%

Peer median across 8 companies: ELAN, BMRN, JAZZ, BBIO, TGTX, SYRE, MDGL, PRAX.

Valuation

Market cap
$12.41B
Price / sales (latest FY)
3.26

Price and trading

Previous close
14.83
Open
14.88
Day range
14.86 – 15.10
52-week range
11.36 – 15.67
52-week change
+7.05%
Beta
—
Volume
1.74M

Dividends and events

Annual dividend
$8.00
Next earnings date
Oct 23, 2026

Additional statistics

Market Cap
12.41B
Pe
41.36
Forward Pe
22.47
Eps
0.36
Dividend Yield
56.00%
Dividend Rate
8.00
Week52 High
15.67
Week52 Low
11.36
Avg Volume
2.85M
Shares Outstanding
833.66M
Ma50
13.34
Ma200
13.31
Earnings Date
Oct 23, 2026
Pct From52w High
-4.98%
Pct From52w Low
31.07%

Related